Redefining the Management of Moderate to Severe VMS due to Menopause: Addressing Diagnosis and Treatment Gaps to Enhance Outcomes for Women | Kisaco Research

A multidisciplinary roundtable discussion focusing on the unmet needs and adverse impact of moderate to severe vasomotor symptoms (VMS) due to menopause on women’s health outcomes.

Sponsor(s): 
Bayer
Speaker(s): 

Author:

Jamie Grossman, PhD, MBA

National Account Director, Health Economics & Outcomes Research
Bayer

Jamie Grossman, PhD, MBA

National Account Director, Health Economics & Outcomes Research
Bayer

Author:

Angie Lee, MD, FACOG

Executive Medical Director, Women’s Health Care
Bayer

Angie Lee, MD, FACOG

Executive Medical Director, Women’s Health Care
Bayer
Session Type: 
General Session (Presentation)